TrialJournal of clinical oncology : official journal of the American Society of Clinical Oncology2021

Survival Impact of Anti-GD2 Antibody Response in a Phase II Ganglioside Vaccine Trial Among Patients With High-Risk Neuroblastoma With Prior Disease Progression.

Irene Y Cheung et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.